BIOA
BioAge Labs, Inc
NASDAQ: BIOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.85
-0.06% today
Updated 2026-04-30
Market cap
$756.98M
P/E ratio
—
P/S ratio
84.16x
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$4 – $24
Volume
0.5M
BioAge Labs, Inc (BIOA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-27.52M | $-22.45M | $-32.20M | $-37.62M | $-29.79M | $-36.18M | $-37.36M | $-51.52M | $-81.63M |
| Capital expenditures | $12.79M | $0.00 | $0.00 | $0.00 | $0.00 | $103000.00 | $166000.00 | $366000.00 | $719000.00 |
| Depreciation | $1.71M | $1.37M | $4.16M | $9.16M | $9.35M | $129000.00 | $162000.00 | $167000.00 | — |
| Stock-based comp | $6.73M | $6.95M | $4.79M | $3.58M | $5.18M | $2.54M | $3.02M | $6.98M | $11.69M |
| Free cash flow | $-40.31M | $-22.45M | $-32.20M | $-37.62M | $-29.79M | $-36.28M | $-37.53M | $-51.89M | $-82.35M |
| Investing cash flow | — | — | — | — | — | $-103000.00 | $-266000.00 | $-366000.00 | — |
| Financing cash flow | $99.92M | $78.65M | $54.89M | $47.22M | $18.85M | $2.50M | $34.94M | $381.20M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |